Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Tuberculosis

No description
by

mariam kavtaria

on 26 November 2017

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Tuberculosis

Tuberculin Skin Testing -
tuberculin purified protein derivative (PPD)
screening for latent M. tuberculosis
low sensitivity and specificity
unable to discriminate between latent infection and active disease.
False-positive reactions may be caused by infections with other mycobacteria and by BCG vaccination.

Thank You!
M. tuberculosis
rod-shaped,
nonspore-forming,
thin
Aerobic
Often neutral on Gram's staining
Acid-fast
bacilli
- cannot be decolorized by acid alcohol
Acid fastness
- high content of
mycolic acids
and other cell-wall lipids.
low permeability of the cell wall - low effectiveness of most antibiotics.
lipoarabinomannan
-facilitates the survival within macrophages.
From Infection to Disease
Primary TB - not associated with high transmissibility.
secondary TB -
is more infectious - Bacilli may persist and reactivate after years
Up to
10% of infected persons
will develop active TB in their lifetime.
The risk is much higher in
HIV-infected persons
The risk that latent M. tuberculosis infection will proceed to active disease is
directly related to the patient's degree of immunosuppression.
the incidence of TB is highest during late adolescence and early adulthood;
the reasons are unclear
Infection and Macrophage Invasion
majority of inhaled bacilli are
trapped in the upper
airways
and expelled by ciliated mucosal cells,
<10%
reach the alveoli.
alveolar macrophages
phagocytize
the bacilli.
1, Phagocytosis
2.Complement activation
3.Opsonization of bacilli (C3b).
bacilli
survive
in the phagosomes.
Replication begins
inside
the macrophage
Macrophage eventually ruptures and releases its bacillary contents.
Other uninfected phagocytic cells ingest these bacilli
thus becoming infected themselves and expanding the infection

DIAGNOSIS
Acid Fast Bacilli Microscopy
inexpensive,
low sensitivity (40–60%)
two or three sputum specimens should be submitted
Transmitted by
droplets:
coughing, sneezing, or speaking.
There may be as many as 3000 infectious nuclei per cough.
The tiny droplets dry rapidly;
the smallest (<5–10micrometers) may remain in the air for several hours
and may reach the terminal air passages when inhaled
duration of contact
and the shared environment - important determinants
TB patients whose
sputum contains Acid-Fast Bacilli
are the most likely to transmit the infection.
The most infectious patients have cavitary pulmonary disease
Patients with sputum -negative/culture-positive TB are less infectious,
Crowding in poorly ventilated rooms
- one of the most important factors in the transmission of tubercle bacilli


Mariam Kavtaria
Tuberculosis
Exposure
M. tuberculosis grows within
naïve - unactivated macrophages
The mycobacteria induces secretion of
matrix metalloproteinase 9 (MMP9)
by epithelial cells
MMP9
stimulates recruitment
of naïve macrophages - inducing more bacterial growth.
Additional naïve macrophages are recruited to the
early granuloma.

M. tuberculosis stimulates secretion of
tumor necrosis factor (TNF-alfa)
and
recruits more inflammatory cells
After repeated bouts of this process,
dendritic cells (APC)
are activated
Dendritic cells
migrate to the lymph nodes
and present mycobacterial antigens to
T lymphocytes.
At this point, the development of Cell Mediated Immunity and humoral immunity begins.
These initial stages of infection are usually
asymptomatic
.
The Host Response and Granuloma Formation
2–4 weeks after infection, two host responses develop:
1.
T cell–mediated macrophage-activating response
-
activation of macrophages
that are capable of killing and digesting tubercle bacilli.
2.
tissue-damaging response
- result of a
delayed-type hypersensitivity (DTH)
reaction to bacillary antigens;
destroys unactivated macrophages that contain multiplying bacilli
causes
caseous necrosis
of the involved tissues

Large numbers of T lymphocytes and activated macrophages
-
Granuloma Formation
the tissue-damaging response can limit mycobacterial growth within macrophages.
this response destroys macrophages and also produces early
solid necrosis in the center
of the tubercle.
M. tuberculosis survives but its
growth is inhibited
within this necrotic environment by low oxygen tension and low pH.
some lesions may
heal by fibrosis
, with subsequent calcification,
inflammation and necrosis occur in other lesions.


1. Macrophages phagocytose bacilli and present it to T lymphocytes

2. Activation and proliferation of
CD4+ T lymphocytes

3. Activated CD4+ T lymphocytes differentiate into
TH1
or
TH2
cells.
TH1 cells produce
IFN - gamma
- activation of
macrophages
and monocytes
TH2 cells produce
IL-4, IL-5, IL-10, and IL-13
-
promote humoral immunity - activation of B cells
defects of CD4+ T cells in
HIV-infected individuals
- Inability to stop mycobacterial proliferation.

4. T lymphocytes activate macrophages by i
nterferon gamma (INF-gamma)

5. activated macrophages
aggregate around the lesion
and neutralize tubercle bacilli without causing further tissue damage
In the central part of the lesion, the
necrotic material
resembles soft cheese (
caseous necrosis
)
Even when healing takes place,
bacilli may remain dormant within macrophages
for many years.
These "healed" lesions may calcify

6. Sometimes the macrophage response is weak, and
mycobacterial growth can be inhibited only by
Delayed Type Hypersensitivity -
leads to lung tissue destruction
The lesion enlarges and the surrounding tissue is progressively damaged
Bronchial walls and blood vessels are destroyed, and
cavities are formed
.
The caseous material, containing large numbers of bacilli, is drained through bronchi.
Within the cavity, tubercle bacilli multiply, spill into the airways, and are discharged into the environment through coughing and talking
.

7. bacilli
are transported by macrophages to regional lymph nodes
from there they
reseed the lungs
and may also disseminate beyond the pulmonary vasculature throughout the body
The resulting extrapulmonary lesions may undergo the same evolution as those in the lungs, although most
tend to hea
l.
In persons with poor immunity, hematogenous dissemination may result in
fatal miliary TB or tuberculous meningitis
normal phagocytosis
may be asymptomatic or present with
fever

In areas of high TB transmission - often seen
in children
.
middle and lower lung zones -
most commonly involved
The Ghon focus
- The lesion after initial infection
is
periphera
l and accompanied by hilar or paratracheal
lymphadenopathy
- may not be visible on chest radiography.
In the majority of cases, the
lesion heals spontaneously
and is seen as a
small calcified nodule
.
Ghon complex
-
The Ghon focus, with overlying pleural reaction, thickening, and regional lymphadenopathy
In persons with impaired Cell Mediated immunity -
primary pulmonary TB may progress to clinical illness
.
Primary pulmonary TB - initial infection with tubercle bacilli.
Pleural effusion -
penetration of bacilli into the pleural space
In severe cases, the primary site rapidly enlarges, its central portion undergoes
necrosis, and cavitation develops
(progressive primary TB).
TB in young children is accompanied by
hilar or paratracheal lymphadenopathy
Enlarged lymph nodes may compress bronchi, causing obstruction with collapse
Lymph nodes may also rupture into the airway

1. Reactivation of latent infection
2. Recent infection (primary infection or reinfection)
.

upper lobes
- higher O2 favors mycobacterial growth.
cavity formation
- necrotic contents are discharged into the airways
1/3 of patients develop
severe pulmonary TB
within a few months
others may undergo
spontaneous remission
or
chronic, progressive course
some pulmonary lesions become fibrotic and calcify,
Individuals with chronic disease continue to discharge bacilli into the environment.
symptoms and signs are often nonspecific and insidious -
low grade fever and night sweats, weight loss,
anorexia, general malaise, and weakness in 80%
cough - up to 90% of cases,

nonproductive cough in the morning and subsequent production of purulent sputum, sometimes bloody

Hemoptysis
in 20–30% of cases
Pleuritic chest pain
sometimes .
Occasionally, rhonchi may be heard.
In some cases,
pallor and finger clubbing
develop.
mild anemia, leukocytosis, and thrombocytosis
slightly
elevated erythrocyte sedimentation rate and/or C-reactive protein
level.

Postprimary Disease
Reactivation or secondary TB
Extrapulmonary TB
1.
lymph node TB
- 35% of patients
painless swelling of the lymph nodes -
Posterior cervical and supraclavicular -
most commonly
pulmonary disease is present in <50% of cases
systemic symptoms - uncommon
The diagnosis - by

fine-needle aspiration biopsy
or surgical excision biopsy





3.
genitourinary tract
- 10–15% of all extrapulmonary cases
Can involve any portion of the genitourinary tract.
Urinary frequency, dysuria, nocturia, hematuria, and flank pain
Urinalysis is abnormal in 90% of cases -
pyuria and hematuria
.

Genital TB is diagnosed more commonly in females - it affects the
fallopian tubes and the endometrium

In males - affects the
epididymis
, producing a slightly tender mass,
orchitis and prostatitis
may also develop
Diagnosis -
biopsy or culture
Genitourinary TB responds well to chemotherapy

2. pleural Effusion
- in 20% of patients.
may resolve spontaneously or may cause symptoms:
fever, pleuritic chest pain, and dyspnea
dullness to percussion and absence of breath sounds.
A chest radiograph reveals the effusion
Needle biopsy of the pleura
- granulomas and a positive culture in up to 80% of cases.
This form of pleural TB
responds rapidly to chemotherapy

Thoracentesis:
Straw colored fluid
Exudate:
protein concentration >50% of that in serum (usually 4–6 g/dL),
a
normal to low glucose
concentration,
a
pH of 7.3
(occasionally <7.2),
white blood cells
(usually 500–6000/L)
lymphocytosis
is the typical finding later.
Tuberculous empyema -
rupture of a cavity, spillage of organisms into the pleural space.
A chest radiograph shows
hydropneumothorax with an air-fluid level
.
The pleural fluid is
purulent and thick
contains
large numbers of lymphocytes
Acid-fast smears and cultures are positive.
Surgical drainage
is required
may result in severe
pleural fibrosis -
Removal of the thickened pleura (decortication) is occasionally necessary to improve lung function
4.
bones and joints
-
10% of extrapulmonary cases.
spread
from adjacent paravertebral lymph nodes
.
Weight-bearing joints -
Spine in 40%, hips in 13%, and knees in 10%)
Spinal TB - Pott's disease - involves vertebral bodies.

CT or MR
I reveals the characteristic lesion
Aspiration
of the abscess or bone
biopsy
.
A catastrophic complication of Pott's disease is

paraplegia
-
due to spinal cord compression.
Paraparesis is a
medical emergency
and requires
rapid drainage
Skeletal TB responds to chemotherapy, but severe cases require surgery.
5.
Meningitis and Tuberculoma
- 5% of extrapulmonary cases
most often in
young children, Adults with HIV
hematogenous
spread
headache
and slight mental changes
low-grade fever, malaise, anorexia, and irritability.

may evolve acutely with severe headache, confusion, lethargy, altered sensorium, and neck rigidity.
paresis of cranial nerves -
ocular nerves
coma, with hydrocephalus and intracranial hypertension.
CSF:
high leukocyte count (up to 1000/L) - predominance of
lymphocytes
,
a protein content of 1–8 g/L (100–800 mg/dL); ,
low glucose concentration.


Culture of CSF -
gold standard
.
PCR
Imaging studies (CT and MRI) - hydrocephalus
Tuberculoma -
one or more space-occupying lesions, causes seizures and focal signs.
CT or MRI reveals contrast-enhanced ring lesions,
biopsy

is necessary to establish the diagnosis.
6.

Gastrointestinal TB
-
3.5% of extrapulmonary cases
swallowing of sputum
with direct seeding, hematogenous spread, or
ingestion of milk from cows
affected by bovine TB.
terminal ileum and the cecum
- most commonly involved.
Abdominal pain
(resembling appendicitis) and swelling, obstruction, hematochezia, and a palpable mass in the abdomen - common findings
Fever, weight loss, anorexia, and night sweats are also common.
Tuberculous peritonitis

- direct spread of tubercle bacilli from ruptured lymph nodes, or hematogenous seeding.
Nonspecific abdominal pain, fever, and ascites
paracentesis
- high protein content and lymphocytosis
peritoneal
biopsy
is often needed


Tuberculous Pericarditis
- direct extension, hematogenous spread
dyspnea, fever, dull retrosternal pain
, and a
pericardial friction rub
Pericardial effusion
signs of cardiac tamponade
pericardiocentesis

under echocardiographic guidance.
The effusion is exudate -
high count of lymphocytes
and monocytes.
pericardial biopsy
Without treatment, pericardial TB is usually fatal.
complications:
constrictive pericarditis
with thickening of the pericardium


Miliary or Disseminated TB
- due to
hematogenous spread
of tubercle bacilli.
yellowish granulomas
1–2 mm in diameter that resemble millet seeds
Fever, night sweats, anorexia, weakness, and weight loss
hepatomegaly, splenomegaly, and lymphadenopathy


Mycobacterial Culture
- grow
slowly
,
4–8 weeks may be required
gold standard

Nucleic Acid Amplification -
diagnosis of TB in several hours
highly sensitive

Radiographic Procedures
"classic" picture of
upper-lobe disease with infiltrates and cavities on X-ray
virtually any radiographic pattern can be seen
CT
- diagnosing extrapulmonary TB (e.g., Pott's disease)
MRI -
diagnosis of intracranial TB.

IFN-gamma Release Assays (IGRA)
- measure T cell release of IFN-gamma in response to stimulation with TB-antigens
positive Tuberkulin Skin Testing should be followed by an IGRA
IGRAs are specific

Treatment
First-line agents:
Isoniazid
Rifampin
Pyrazinamide
Ethambutol


Regimens
initial phase:
the majority of the bacilli are killed, symptoms resolve, patient becomes noninfectious.
The continuation phase:
to eliminate persisting mycobacteria and prevent relapse
2-month initial phase of

isoniazid, rifampin, pyrazinamide, and ethambutol

followed by a
4-month continuation phase
of isoniazid and rifampin
For patients with
sputum culture–negative pulmonary TB,
the duration of treatment may be reduced to a total of 4 months.
To prevent
isoniazid-related neuropathy-
pyridoxine
should be added to the regimen given to persons at high risk of vitamin B6 deficiency


Monthly sputum examination until cultures become negative.
>80% of patients - negative sputum cultures
at the end of the 2nd month of treatment
.
By the
3rd month

all patients
should be culture-negative
If sputum cultures remain positive at 3 months - treatment failure and drug resistance should be suspected
a chest radiograph at the end of treatment - useful for comparing
Patients should be monitored for drug toxicities:
The most common adverse reaction is
hepatitis
.
Patients should be educated about symptoms of drug-induced hepatitis ( dark urine, loss of appetite)
all adult patients should undergo assessment of liver function
Symptomatic hepatitis and those with marked (
five- to sixfold
) elevations in serum levels of AST-
treatment should be stopped
and drugs reintroduced
one at a time
after liver function has returned to normal.
Hyperuricemia and arthralgia
caused by pyrazinamide - managed by the administration of acetylsalicylic acid;
pyrazinamide treatment should be stopped if the patient develops gouty arthritis.
autoimmune thrombocytopenia
secondary to rifampin therapy
optic neuritis
with ethambutol is an indication for
permanent discontinuation
of this drug
.
isoniazid-related
neuropathy
- pyridoxine (B6) should be added to drug regimen

Monitoring
Neuropathy
Orange body Fluids
Gout, Photosensitivity
Optic Neuritis
BCG Vaccination

BCG was derived from an
attenuated M. bovis
and was first administered to humans in 1921.
BCG vaccine - safe and rarely causes serious complications.
The local tissue response begins 2–3 weeks after vaccination,
scar formation and healing within 3 months.
Side effects—most commonly,
ulceration at the vaccination site and regional lymphadenitis
—occur in 1–10% of vaccinated persons.
Some vaccine strains have caused osteomyelitis in
1 case per million doses
administered.
BCG vaccine is recommended for
routine use at birth in countries with high TB prevalence
.
Because of the low risk of transmission of TB in the United States and the unreliable protection afforded by BCG - the vaccine
has never been recommended in the United States.
HIV-infected adults and children should
not
receive BCG vaccine.

References:
1. The Merck Manual of Diagnosis and Therapy - 19th Edition
2. Harrison's Principles of Internal Medicine - 18th edition
Estimated tuberculosis incidence rates in 2013 (per 100,000 population)
ACTIVATION OF T cells
MAJOR SIDE -EFFECTS:
Full transcript